Although the frequency of NTR1 expression in primary tumors and metastatic lymph nodes appears to be lower than that of PSMA, investigating PSMA-negative (on IHC or PET imaging) prostate tumors would be of particular interest. Here, NTSR1 is linked to prostate neoplasm.